<DOC>
	<DOCNO>NCT01965522</DOCNO>
	<brief_summary>Investigators plan carry study investigate two different pill , Vitamin D melatonin , whether reduce spread cancer cell tumor woman breast cancer . These pill inexpensive side effect . A large number study use cell culture animal show vitamin D melatonin help destroy breast cancer cell . However thoughtful well-designed study necessary human see decrease spread breast cancer , possibly even prevent breast cancer . The propose study aim understand anti-cancer activity vitamin D melatonin . This knowledge assist create efficient cancer prevention strategy Canadians . This study include woman breast cancer plan surgery , ass whether treatment vitamin D ( dose 2000 IU per day ) group 36 woman , melatonin ( dose 20mg per day ) another group 36 woman , pill together yet another group 36 woman , reduces spread cancer cell compare fourth group 36 woman treat sugar pill . To measure substance blood call Ki67 , provide information spread cancer . Investigators compare Ki67 level 4 group , woman receive identical appear pill know treatment receive .</brief_summary>
	<brief_title>Anti-proliferative Effects Vitamin D Melatonin Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>Woman histologically confirm invasive breast cancer ( ductal , lobular , mixed ) Planned undergo definitive surgery , either lumpectomy mastectomy 3 week Less 18 year age Stage IIIB IV disease Inoperable locally advance metastatic breast cancer Neoadjuvant chemotherapy intend Currently take vitamin D supplement Currently take melatonin supplement Previously take vitamin D melatonin supplement within last 3 month Currently take multivitamin willing discontinue duration study Hyperparathyroid disease calcium disturbance past five year Active renal stone last six month Renal failure ( creatinine &gt; 190 mmol/L ) Hypercalcemia ( serum calcium &gt; 2.6 mmol/L ) Known pregnancy Participation another clinical trial patient receive investigational product Unwilling unable provide inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>melatonin</keyword>
	<keyword>vitamin</keyword>
	<keyword>ki67</keyword>
</DOC>